Translating promising research findings into effective therapies presents a formidable challenge. This complex process is often plagued by roadblocks, ranging from basic biological complexities to legal hurdles. Bridging this gap requires a multifaceted approach that combines rigorous preclinical research, collaborative partnerships, and efficient